Landmark Study: Comparing Librela™ (Bedinvetmab) to the NSAID Meloxicam (Zoetis) - Evening Session

Landmark Study: Comparing Librela™ (Bedinvetmab) to the NSAID Meloxicam (Zoetis) - Evening Session

Saturday, January 25, 2025 5:45 PM to 6:45 PM · 1 hr. (America/New_York)
S330 A
Analgesia-Pain ManagementGeneral PracticeOrthopedics

Information

This is the first study to compare bedinvetmab to a NSAID for the control of osteoarthritis-related pain in dogs. In this session, Dr. John Innes will discuss the findings of the study including head-to-head comparisons of product efficacy and safety.

CE Credit
1
Primary Discipline
Small Animal
Secondary Discipline
Canine
Learning Level
Intermediate
Manuscript
Manuscript NOT Available

Join the event!

See all the content and easy-to-use features by logging in or registering!